Skip to main content
. 2023 Jan 1;24(1):762. doi: 10.3390/ijms24010762

Figure 5.

Figure 5

EVFEtOH and rutaecarpine block entry of the omicron pseudovirus into HEK293T cells overexpressing ACE2. (A) EVFEtOH and (B) rutaecarpine both blocked omicron pseudovirus entry in dose-response manners. SARS-CoV-2 neutralising antibody was used at 1 µg/mL, as a positive control. The data represent the mean ± SD percentage of inhibition to control (with no drug treatment) and n = 3.